This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Wake Forest University. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Siqun Lilly Zheng: Inventor in Genetic Risk Assessment
Introduction
Siqun Lilly Zheng is an inventor associated with Wake Forest University and based in Clemmons, North Carolina. Her reported work includes inventions focused on using genetic markers to assess prostate cancer risk. She is credited with 3 patents.
Latest Patents
One of Zheng’s listed inventions, “Methods and Compositions for Correlating Genetic Markers with Prostate Cancer Risk,” describes assessing an individual’s risk by analyzing genetic material and determining genotypes at multiple biallelic polymorphic loci. The method calculates a cumulative relative risk (CRR) from those genotypes. A CRR greater than 1.00 indicates increased risk and may help identify people who could be candidates for earlier PSA screening, prostate biopsy, or chemoprevention.
Career Highlights
Zheng’s reported patent work connects genetic-marker analysis with individualized prostate cancer risk assessment. The described approach combines information from multiple genetic loci to produce a cumulative risk measure.
Collaborations
Zheng’s listed coworkers include Andrew Karim Kader and Jianfeng Xu. Her work is associated with Wake Forest University.
Conclusion
Siqun Lilly Zheng’s reported inventions apply genetic information to prostate cancer risk assessment, with the aim of supporting earlier identification of individuals who may benefit from further evaluation or preventive care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile